Holidays don’t have to be the only time families get together to share a meal and create lasting memories. We all know the benefits of family time – tighter bonds, better communication and memorable traditions, and recent studies confirm all the positive effect of family time, especially in children.
Sierra Mist Natural is teaming up with Chef Aarón Sánchez, star of Food Network’s “Chopped” and “Heat Seekers,” to launch “Comer Juntos: Una Tradición Natural,” a program that encourages families to gather around the dinner table to share fun timesover delicious Latin-inspired food and drinks.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55544-sierra-mist-natural-food-network-chef-aaron-sanchez-celebrate-family-meal
Leading scientists have released the latest results of the large scale trials related to nuts consumption and health, particularly in myocardial infarction, stroke and cardiovascular diseases. Recent scientific studies show the benefits of regular intake of nuts, not only associated with cardiovascular health but also with renal function, diabetes, cognitive function, atherosclerosis, metabolic syndrome, inflammatory biomarkers, etc. It is important to highlight that scientific evidence demonstrates that eating nuts is not associated with a higher risk of weight gain, and even reinforce their importance as sources of key nutrients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62432-scientifically-proven-nuts-are-not-fattening
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
In the U.S., Americans’ perception of Mexico has reached a 10-year high, according to a recent Gallup, Inc. poll. The statistic further highlights the country’s record-breaking 2016 tourism year that saw more than 35 million international visitors - up 9% from the year prior - enjoying its world-class beaches and cultural offerings, according to the Mexico Tourism Board.
Credit for the country’s recent successes in tourism is largely due to the Mexican people - widely recognized as some of the friendliest and most welcoming in the world, and their centuries-old spirit of hospitality. Mexico Tourism Board’s internal consumer tracking studies showed more than 94 percent of visitors reported an experience that “exceeded their expectations” and 86 percent said they would “like to come back again” in the next six months– some of the highest scores in the industry, attesting to the popular Mexican adage, ‘mi casa es su casa’ (my home is your home).
To view the multimedia release go to:
https://www.multivu.com/players/English/8086151-mexico-tourism-gallup-poll/
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
Nearly six of ten Americans will develop kidney disease in their lifetime, according to a new analysis published in the American Journal of Kidney Diseases. In comparison, lifetime risk of diabetes, heart attack and invasive cancer is approximately four in ten.
As a result of this and previous studies, the National Kidney Foundation is calling on healthcare professionals to screen patients in specific high-risk groups for kidney disease – those age 60 or older and those with high blood pressure or diabetes – by adding a simple urine albumin test for kidney damage to annual physical examinations.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62772-national-kidney-foundation-study-screening-for-disease
The First Graduation Ceremony of Nazarbayev University (NU) took place on June 15, 2015. The President of Kazakhstan, Nursultan Nazarbayev addressed the Class of 2015.
Nazarbayev University, created on the initiative of the President of Kazakhstan in 2010, is fast becoming a leading research university in Kazakhstan and the region. The first cohort of graduating students consists of 446 undergraduate and graduate students. Of the 365 bachelor degree holders, 115 have been accepted to Masters and PhD programs in leading universities of the world, some 90 graduates plan to continue their studies at Nazarbayev University; more than 80 received job offers from leading national and international companies, and another 50 are interviewing with prospective employers.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7560951-nazarbayev-university-graduation-ceremony/
As soon as you start feeling run down or have other flu-like symptoms, take Oscillococcinum.
Oscillo® is supported by published clinical studies, as well as more than 65 years of use throughout the world.
-Clinical studies show that Oscillo reduces the severity and duration of flu-like symptoms such as headache, body aches, chills and fever
-Great taste and convenient to take
-No side effects; no drug interactions; non-drowsy
-Safe for everyone 2 years of age and older
To view Multimedia News Release, go to http://www.multivu.com/players/English/45775-Boiron-Oscillococcinum/
This video is a dedication to all my friends at IBS Mumbai who have created a great impact in my life. These two years have really been so special for all of Us. I'm sure we're all gonna miss our college days. Specially those who wont be going for further studies (FURTHER STUDIES!!!!!! INSANE!!!). This would be the last spice of college life they would get....... The video mainly is based of the photos of my close friend circle, particularly Section C. But its dedicated to the whole Batch of 2010... Pardon me if I have missed few faces.. Did this the night of FRM exam... Total time taken... 4hrs. 45 min... But I thought its the last chance. To say thanks.. For being so special!!!!
The holiday season provides the perfect opportunity to give thanks and to give back to youth who are facing challenges within our communities. In days of uncertainty, there are still people who are providing direction and mentoring to high-risk youth to help them succeed in spite of the unfortunate circumstances they may have encountered. Many studies indicate that a young person’s success can be greatly enhanced by an advocate or mentor — an adult who consistently helps a young person stay on track to graduate and make better life choices. Goodwill’s GoodGuides program is the source of many modern-day mentoring success stories.
The GoodGuides program provides mentoring to youth, ages 12–17, who are at risk of dropping out of school and/or falling into delinquency. The program helps them finish school, transition into the world of work and prepare for success by pairing them with trusted adult volunteer mentors. Mentors help youth overcome disadvantages such as failure in school due to poor grades or low attendance, or avoid delinquency due to issues such as abuse, disability, drug or alcohol dependence, family violence or gang membership.
To view the multimedia release go to:
http://www.multivu.com/players/English/7057252-goodwill-givegoodwill-campaign/
As school dismisses for the summer, students of all ages look forward to the carefree days of summertime, but many kids experience what is called the “summer slide.” Studies show that kids can lose up to two months of learning. Kumon, the world’s largest after-school math and reading program, is offering free registration at participating learning centers from June 1-30 to help students continue learning through the summer months.
While a break from the mental taxation of school is needed, challenging children year round is the key to having a strong start the following school year.
“Students can avoid summer learning loss by keeping their minds active and absorbing new knowledge,” said Dominique Ciccarelli, Ed. M., education specialist for Kumon North America. “Continuous study throughout the summer helps ease students into the new school year with sharper skills and enables them to tackle new challenges.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7720257-kumon-free-registration/
